Caused by the worldwide spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the coronavirus disease 2019 (COVID-19) pandemic continues
What is a protective neutralizing antibody titer against SARS-CoV-2 infection?
SARS-CoV-2 can infect blood monocytes and trigger inflammation, finds study
Researchers found about 10% of blood monocytes in coronavirus disease 2019 (COVID-19) patients are infected with severe acute respiratory syndrome
Study reports lasting immune response in convalescent COVID-19 patients
Using different types of assays, researchers found both cellular and humoral immune responses for up to eight months in coronavirus
Dried blood spot sampling offers an inexpensive way to widen access to antibody testing for COVID-19
Using dried blood spot samples (DBS) is an accurate alternative to venous blood in detecting SARS-CoV-2 antibody tests, a new
Antibody study suggests more lasting immunity against COVID than believed
(HealthDay)—In a finding that should encourage scientists who are racing to develop coronavirus vaccines, a new study out of Iceland
Monoclonal antibody against COVID-19 enters clinical trial
On June 5, 2020, China’s National Medical Products Administration (NMPA) officially approved the clinical trials for a fully human monoclonal
TET proteins regulate factors essential for normal antibody production
A family of cancer suppressive proteins, known as TET proteins, help regulate gene activity via their influence on chromosomal architecture.
Antibody blocks inflammation, protects mice from hardened arteries and liver disease
Researchers at University of California San Diego School of Medicine discovered that they can block inflammation in mice with a